Contact
About Abbott
cardiovascular
MY ACCOUNT

Absolute Pro™
Peripheral Self-Expanding Stent System

Ordering Information
Absolute Pro Vascular

Precision. Performance. Results.

Excellent precision, flexibility, and proven clinical results1 in the iliacs.

Precision

  • Tri-axial technology to ensure precise stent placement

Performance

  • Flexible nitinol material
  • 12 radiopaque nitinol markers (6 on each end) for visibility

Clinical Results

  • 98.9% clinically driven freedom from TLR at 9 months
  • 92.1% primary patency at 2 years in iliacs1
  • 84.8% primary patency in TASC D lesions at 2 years in iliacs*1

High Freedom from Clinically Driven TLR through 3 years

High Freedom from Clinically Driven TLR through 3 years

Significant Sustained Improvement in Walking Capacity

walking capacity chart

Tri-Axial Technology Specifications

Tri-Axial Technology Specs

Stent Size Matrix

Lengths (mm)
 2030406080100
Stent Diameter (mm)6.06F/8F6F/8F6F/8F6F/8F
6F/8F
6F/8F
7.06F/8F
6F/8F
6F/8F6F/8F6F/8F6F/8F
8.06F/8F6F/8F6F/8F6F/8F6F/8F6F/8F
9.06F/8F6F/8F6F/8F6F/8F6F/8F6F/8F
10.06F/8F6F/8F6F/8F6F/8F6F/8F6F/8F
Sheath/Guide Compatibility

Compatible with 0.035" guide wire only - use of an undersized guide wire with insufficient support may cause kinking in the stent delivery system.**

Data on file at Abbott.
*Combined clinical results from BRAVISSIMO study where 54%/46% of TASC D lesions were treated with Absolute Pro™ Vascular Self-Expanding Stent System / Omnilink Elite™ Vascular Balloon-Expandable Stent System respectively.
**Absolute Pro™ .035 Self-Expanding Stent System Instructions For Use (IFU). Refer to IFU for additional information.

References

  1. Donato, G. et al. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions. Annals of Vascular Surgery. 2015; 29(4): 738-750.

MAT-2405571 V1.0

POLICIES
LOGIN & REGISTRATION
Abbott logo

Information contained herein for distribution in Australia and New Zealand only.
CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.
Abbott Vascular division of Abbott Medical New Zealand Ltd, Grd Flr, Bldg. D, 4 Pacific Rise Mt Wellington, Auckland 1060 Tel: 0800 827 285
Abbott Vascular division of Abbott Medical Australia Pty Ltd, 299 Lane Cove Road, Macquarie Park NSW 2113, Tel: 1800 550 939
© 2025 Abbott. All Rights Reserved.
MAT-2105201 v7.0

Disclaimer

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

 

Do you wish to continue and enter this website?

MAT-2105201 v1.0